CTRI/2015/05/005830
Recruiting
Phase 4
Safety and efficacy profile of oral cyclosporine versus oral methotrexate versus oral acitretin in palmoplantar psoriasis and psoriasis vulgaris â?? A hospital based prospective investigator blind randomized controlled comparative study.
Krishna Institute of Medical Sciences Deemed University0 sites120 target enrollmentTBD
Overview
- Phase
- Phase 4
- Intervention
- Not specified
- Conditions
- Health Condition 1: null- Palmoplantar psoriasis and psoriasis vulgaris
- Sponsor
- Krishna Institute of Medical Sciences Deemed University
- Enrollment
- 120
- Status
- Recruiting
- Last Updated
- 4 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •A.Have given written consent before any treatment commenced.
- •B.Be diagnosed to be suffering exclusively from Palmo\-plantar psoriasis either by clinical examination or histopathology if required will be included in palmoplantar psoriasis group.
- •C.Be diagnosed to be suffering from psoriasis vulgaris having more than 20% body surface area will be included in psoriasis vulgaris group.
- •D.Have completed 18 years of age.
- •E.Have to stop any other modality of treatment, two months prior to the inclusion in study.
- •F.Be able and willing, in the view of investigator, to comply all study procedure.
Exclusion Criteria
- •A.Patient with hypersensitivity to drug or patient intolerant to the study medication.
- •B.Pregnant and lactating patient.
- •C.Patient with Unrealistic expectations.
- •D.Not willing for regular follow up.
- •E.Patient with clinically significant cardiovascular, haematological, pancreatic, metabolic neurological or any other laboratory anomaly, which in the judgement of investigator, would interfere in participation in study or proper evaluation.
- •F.Patient on any other systemic drugs therapy which in the judgement of investigator may interfere with interpretation of results.
- •G.Patient having history of tuberculosis or chest X\-ray showing evidence of any infective pathology.
Outcomes
Primary Outcomes
Not specified
Similar Trials
Completed
Not Applicable
The clinical effects and safty of cyclosporine with rootine corticosteroid treatment in onset MCNSminimal change nephrotic syndromeJPRN-UMIN000004653Yokohama city university graduate school of medicine20
Not yet recruiting
Phase 4
To compare safety and efficacy of cyclosporine 0.05% and cyclosporine 0.09% eyedrops for dry eye (keratoconjunctivitis).Dry Eye SyndromeJPRN-UMIN000035991aser Eye Clinic Noida40
Completed
Phase 3
ano-Tacrolimus and Cyclosporine effect in dry eyeIRCT20181006041253N1Birjand University of Medical Sciences24
Completed
Not Applicable
Efficacy and safety of cyclosporine and steroid for the treatment of minimal change nephrotic syndromeMinimal change nephrotic syndromeJPRN-UMIN000000963Yoshihiko Saito30
Completed
Not Applicable
The efficacy of 0.05% cyclosporin eye drop for dry eye diseaseDiseases of the eye and adnexaKCT0006923Pusan National University Hospital64